MFS Discloses 6.8% Stake in Boston Scientific

TL;DR

**MFS owns 6.8% of Boston Scientific, signaling institutional confidence.**

AI Summary

Massachusetts Financial Services Company (MFS) filed an amended SC 13G/A on February 9, 2024, disclosing its beneficial ownership in Boston Scientific Corporation as of December 29, 2023. MFS now holds sole voting power over 49,717,745 shares of Boston Scientific's common stock, representing 6.8% of the company. This filing indicates a significant institutional investor maintains a substantial stake, which can signal confidence in the company's long-term prospects for current and potential shareholders.

Why It Matters

This filing shows a major institutional investor, MFS, holds a significant position in Boston Scientific, which can be seen as a vote of confidence in the company's future performance.

Risk Assessment

Risk Level: low — This filing indicates a stable, significant institutional ownership, which generally reduces volatility and risk.

Analyst Insight

A smart investor would view this as a positive signal, indicating that a large, sophisticated institutional investor sees value in Boston Scientific, potentially prompting further research into the company's fundamentals.

Key Numbers

• 49,717,745 — Shares Beneficially Owned (Represents the total number of shares of Boston Scientific common stock over which MFS has sole voting power as of December 29, 2023.)
• 6.8% — Percentage of Class (Indicates the significant stake MFS holds in Boston Scientific, showing a substantial institutional investment.)

Key Players & Entities

• Massachusetts Financial Services Company (company) — the reporting person and institutional investor
• Boston Scientific Corporation (company) — the subject company in which shares are owned
• 49,717,745 (dollar_amount) — number of shares beneficially owned with sole voting power by MFS
• 6.8% (dollar_amount) — percentage of Boston Scientific's common stock owned by MFS
• December 29, 2023 (date) — the date of the event requiring the filing
• February 9, 2024 (date) — the filing date of the SC 13G/A

Forward-Looking Statements

• MFS will maintain its significant stake in Boston Scientific for the foreseeable future. (Massachusetts Financial Services Company) — medium confidence, target: December 29, 2024

FAQ

From the Filing

0000912938-24-000242.txt : 20240209 0000912938-24-000242.hdr.sgml : 20240209 20240209114903 ACCESSION NUMBER: 0000912938-24-000242 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240209 DATE AS OF CHANGE: 20240209 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-43484 FILM NUMBER: 24613269 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MASSACHUSETTS FINANCIAL SERVICES CO /MA/ CENTRAL INDEX KEY: 0000912938 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 111 HUNTINGTON AVENUE STREET 2: 24TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 18006372929 MAIL ADDRESS: STREET 1: 111 HUNTINGTON AVENUE STREET 2: 24TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 SC 13G/A 1 SEC13G_Filing.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 ) * BOSTON SCIENTIFIC CORPORATION (Name of Issuer) Common Stock (Title of Class of Securities) 101137107 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.) CUSIP No. 101137107 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Massachusetts Financial Services Company ("MFS") 04-2747644 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] Not Applicable 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 49,717,745 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 57,175,974 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 57,175,974 shares of Common Stock consisting of shares beneficially owned by MFS and/or certain other non-reporting entities 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES Not Applicable 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 3.9% 12. TYPE OF REPORTING PERSON IA Item 1. (a) Name of Issuer BOSTON SCIENTIFIC CORPORATION (b) Address of Issuer's Principal Executive Offices 300 Boston Scientific Way, Marlborough, MA 01752-1234 Item 2. (a) Name of Person Filing Massachusetts Financial Services Company (b) Address of Principal Business Office or, if None, Residence 111 Huntington Avenue, Boston, MA 02199 (c) Citizenship Delaware (d) Title of Class of Securities Common Stock (e) CUSIP Number 101137107 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (